This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: National Institute of Health and Medical Research. Active years: 2013-2017.
Company Filing History:
Years Active: 2013-2017
Title: Cecilia Frecha: Innovator in Vector Particle Technology
Introduction
Cecilia Frecha is a prominent inventor based in Lyons, France. She has made significant contributions to the field of biotechnology, particularly in the development of vector particles for targeted cell therapy. With a total of 2 patents, her work is paving the way for advancements in medical treatments.
Latest Patents
One of Cecilia's latest patents focuses on vector particles for targeting CD34+ cells. This invention relates to a vector particle designed for transferring biological material into cells. The vector particle comprises a first protein that includes the transmembrane and extracellular domains of the feline endogenous RD114 virus envelope glycoprotein. Additionally, it features a second protein that acts as a ligand for the c-Kit receptor. This innovative approach has the potential to enhance the efficacy of targeted therapies.
Career Highlights
Cecilia Frecha is affiliated with the Institut National de la Santé et de la Recherche Médicale, where she continues to advance her research. Her work is characterized by a commitment to improving medical technologies and patient outcomes.
Collaborations
Cecilia has collaborated with notable colleagues, including Els Verhoeyen and Caroline Costa. These partnerships have contributed to her success and the impact of her inventions in the field.
Conclusion
Cecilia Frecha is a trailblazer in vector particle technology, with her innovative patents and collaborations driving progress in biotechnology. Her contributions are essential for the future of targeted therapies and medical advancements.